Quintiles $1.95 billion financing

Overview:

• Biopharmaceutical company Quintiles has obtained $1.95 billion in financing. 
• The financing consisted of an $850 million term a loan, a $600 million term b loan and a $500 million revolving credit facility.
• The proceeds will be used to refinance existing debt and for general corporate purposes. 
• The lenders included JP Morgan Securities, Barclays Bank and Morgan Stanley Senior Funding.
• JPMorgan Chase acted as administrative agent. 

Kurt Stumpo - Journalist